Novozymes A/S · Bagsværd Denmark (OMX Copenhagen: NZYM)
Key Novozymes A/S Financials
| Company Type | Public -(OMX Copenhagen: NZYM) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2004 Sales (mil.) | $1,104.2 |
| 2010 Employees | 5,432 |
Novozymes A/S Income Statement
| Dec 04 | Dec 03 | Dec 02 | |
| Revenue | 1,104.2 | 978.4 | 796.1 |
| Cost of Goods Sold | 521.5 | 471.9 | 385.8 |
| Gross Profit | 582.7 | 506.5 | 410.3 |
| Gross Profit Margin | 52.8% | 51.8% | 51.5% |
| SG&A Expense | 246.5 | 222.0 | 184.0 |
| Depreciation & Amortization | -- | -- | -- |
| Operating Income | 199.8 | 165.6 | 133.6 |
| Operating Margin | 18.1% | 16.9% | 16.8% |
| Nonoperating Income | 0.0 | 0.0 | 0.0 |
| Nonoperating Expenses | (1.6) | 5.6 | (6.6) |
| Income Before Taxes | 198.1 | 171.1 | 127.0 |
| Income Taxes | 52.8 | 47.2 | 35.7 |
| Net Income After Taxes | 145.4 | 123.9 | 91.3 |
| Continuing Operations | 145.4 | 123.9 | 91.3 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 145.4 | 123.9 | 91.3 |
| Total Net Income | 145.4 | 123.9 | 91.3 |
| Net Profit Margin | 13.2% | 12.7% | 11.5% |
| Diluted EPS from Total Net Income | 0.41 | 0.35 | 0.25 |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
Novozymes A/S Balance Sheet
| Assets | Dec 04 | Dec 03 | Dec 02 |
| Current Assets | |||
| Cash | 97.3 | 96.3 | 117.4 |
| Net Receivables | -- | -- | -- |
| Inventories | 207.1 | 188.3 | 186.0 |
| Other Current Assets | 271.3 | 274.5 | 229.4 |
| Total Current Assets | 575.7 | 559.1 | 532.8 |
| Net Fixed Assets | 645.6 | 637.8 | 562.3 |
| Other Noncurrent Assets | 86.3 | 90.0 | 83.1 |
| Total Assets | 1,307.7 | 1,286.9 | 1,178.2 |
| Liabilities | Dec 04 | Dec 03 | Dec 02 |
| Current Liabilities | |||
| Accounts Payable | 37.0 | 35.1 | 36.0 |
| Short-Term Debt | -- | -- | -- |
| Other Current Liabilities | 187.1 | 209.2 | 127.7 |
| Total Current Liabilities | 224.2 | 244.3 | 163.7 |
| Long-Term Debt | -- | -- | -- |
| Other Noncurrent Liabilities | 370.1 | 338.7 | 415.1 |
| Total Liabilities | 594.3 | 583.0 | 578.8 |
| Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 707.5 | 698.7 | 586.3 |
| Total Equity | 707.5 | 698.7 | 586.3 |
| Shares Outstanding (thou.) | 363,000.0 | 377,194.2 | -- |
All amounts in millions of US Dollars except per share amounts.
Novozymes A/S Cash Flow Statement
| Dec 04 | Dec 03 | Dec 02 | |
| Net Operating Cash Flow | 236 | 232 | 167 |
| Net Investing Cash Flow | (37.9) | (96.8) | (85.5) |
| Net Financing Cash Flow | (188.6) | (168.3) | (51.9) |
| Net Change in Cash | 8.6 | (32.4) | 31.2 |
| Depreciation & Amortization | |||
| Capital Expenditures | (51.5) | (66.6) | (51.8) |
| Cash Dividends Paid | (39.8) | (27.3) | (20.6) |
All amounts in millions of US Dollars except per share amounts.